tiprankstipranks
Trending News
More News >
Inmune Bio (INMB)
NASDAQ:INMB
US Market

Inmune Bio (INMB) Ratios

Compare
876 Followers

Inmune Bio Ratios

INMB's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, INMB's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.17 3.14 2.16 5.92 18.95
Quick Ratio
4.17 3.14 2.16 5.92 20.21
Cash Ratio
3.77 2.90 1.94 4.78 17.16
Solvency Ratio
-6.25 -5.56 -0.01 -0.06 -0.06
Operating Cash Flow Ratio
-4.17 -4.62 -0.65 -2.08 -6.54
Short-Term Operating Cash Flow Coverage
0.00 0.00 -1.21 -4.54 -395.89
Net Current Asset Value
$ 22.69M$ 15.20M$ 21.08M$ 42.98M$ 62.89M
Leverage Ratios
Debt-to-Assets Ratio
0.03 <0.01 0.18 0.19 0.15
Debt-to-Equity Ratio
0.04 0.01 0.27 0.25 0.19
Debt-to-Capital Ratio
0.04 0.01 0.21 0.20 0.16
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.14 0.15
Financial Leverage Ratio
1.31 1.23 1.49 1.36 1.25
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.05 0.13 0.09
Interest Debt Per Share
0.04 0.02 0.58 0.85 0.94
Net Debt to EBITDA
0.79 0.49 0.00 0.00 0.00
Profitability Margins
Gross Profit Margin
44.00%100.00%100.00%100.00%100.00%
EBIT Margin
-67304.00%-304535.71%-19187.74%-6938.77%-16106.63%
EBITDA Margin
-67248.00%-300585.71%0.00%0.00%0.00%
Operating Profit Margin
-102752.00%-304535.71%-19187.74%-6938.77%-16106.63%
Pretax Profit Margin
-99774.00%-300585.71%-19360.00%-7299.20%-16762.43%
Net Profit Margin
-99774.00%-300585.71%-19360.00%-7299.20%-16762.43%
Continuous Operations Profit Margin
-99774.00%-300585.71%-19360.00%-7299.20%-16762.43%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
97.10%98.70%100.90%105.19%104.07%
Return on Assets (ROA)
-149.55%-106.37%-52.64%-33.37%-30.36%
Return on Equity (ROE)
-172.00%-131.11%-78.68%-45.42%-37.82%
Return on Capital Employed (ROCE)
-197.59%-131.83%-77.18%-36.61%-30.50%
Return on Invested Capital (ROIC)
-194.18%-131.26%-61.23%-34.16%-30.45%
Return on Tangible Assets
-149.55%-182.58%-74.12%-41.82%-36.37%
Earnings Yield
-159.01%-45.18%-14.82%-24.02%-18.44%
Efficiency Ratios
Receivables Turnover
0.02 <0.01 0.06 0.04 0.03
Payables Turnover
<0.01 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.05 0.05 0.37 0.74 0.25
Asset Turnover
<0.01 <0.01 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Cash Conversion Cycle
-71.96K 36.73K 5.75K 8.26K 11.10K
Days of Sales Outstanding
17.99K 36.73K 5.75K 8.26K 11.10K
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
89.95K 0.00 0.00 0.00 0.00
Operating Cycle
17.99K 36.73K 5.75K 8.26K 11.10K
Cash Flow Ratios
Operating Cash Flow Per Share
-1.15 -1.67 -0.67 -1.27 -1.77
Free Cash Flow Per Share
-1.19 -1.67 -0.67 -1.27 -2.70
CapEx Per Share
0.03 0.00 0.00 0.00 0.93
Free Cash Flow to Operating Cash Flow
1.03 1.00 1.00 1.00 1.53
Dividend Paid and CapEx Coverage Ratio
-34.09 0.00 0.00 0.00 -1.90
Capital Expenditure Coverage Ratio
-34.09 0.00 0.00 0.00 -1.90
Operating Cash Flow Coverage Ratio
-28.38 -86.88 -1.15 -1.48 -1.87
Operating Cash Flow to Sales Ratio
-613.02 -2.38K -77.29 -60.66 -157.48
Free Cash Flow Yield
-100.56%-35.82%-5.92%-19.96%-26.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.65 -2.21 -6.75 -4.16 -5.42
Price-to-Sales (P/S) Ratio
648.68 6.65K 1.31K 303.90 909.04
Price-to-Book (P/B) Ratio
1.28 2.90 5.31 1.89 2.05
Price-to-Free Cash Flow (P/FCF) Ratio
-1.03 -2.79 -16.90 -5.01 -3.78
Price-to-Operating Cash Flow Ratio
-1.06 -2.79 -16.90 -5.01 -5.77
Price-to-Earnings Growth (PEG) Ratio
-0.04 -0.08 -0.68 0.22 -0.06
Price-to-Fair Value
1.28 2.90 5.31 1.89 2.05
Enterprise Value Multiple
-0.17 -1.73 0.00 0.00 0.00
Enterprise Value
4.72M 72.60M 177.06M 76.81M 104.96M
EV to EBITDA
-0.14 -1.73 0.00 0.00 0.00
EV to Sales
94.39 5.19K 1.14K 205.39 579.89
EV to Free Cash Flow
-0.15 -2.18 -14.78 -3.39 -2.41
EV to Operating Cash Flow
-0.15 -2.18 -14.78 -3.39 -3.68
Tangible Book Value Per Share
0.95 0.78 1.20 2.43 3.95
Shareholders’ Equity Per Share
0.95 1.61 2.12 3.35 4.97
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 <0.01 0.02 0.01
Net Income Per Share
-1.88 -2.11 -1.67 -1.52 -1.88
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.48 0.99 1.01 1.05 1.04
Research & Development to Revenue
513.66 2.37K 130.79 45.63 113.50
SG&A to Revenue
133.66 677.36 62.08 24.75 48.57
Stock-Based Compensation to Revenue
167.02 543.21 47.54 19.11 26.50
Income Quality
0.61 0.79 0.40 0.83 0.94
Currency in USD